TriaGen Wealth Management LLC Makes New $394,000 Investment in Waters Co. (NYSE:WAT)

TriaGen Wealth Management LLC acquired a new stake in Waters Co. (NYSE:WAT) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,103 shares of the medical instruments supplier’s stock, valued at approximately $394,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Bailard Inc. boosted its position in shares of Waters by 1.2% in the 2nd quarter. Bailard Inc. now owns 2,034 shares of the medical instruments supplier’s stock valued at $703,000 after purchasing an additional 25 shares during the period. Seeyond boosted its stake in Waters by 0.5% in the second quarter. Seeyond now owns 5,543 shares of the medical instruments supplier’s stock valued at $1,915,000 after acquiring an additional 25 shares during the period. Berman Capital Advisors LLC raised its holdings in Waters by 16.2% during the third quarter. Berman Capital Advisors LLC now owns 208 shares of the medical instruments supplier’s stock worth $74,000 after purchasing an additional 29 shares in the last quarter. Allworth Financial LP raised its stake in Waters by 24.0% during the 3rd quarter. Allworth Financial LP now owns 155 shares of the medical instruments supplier’s stock valued at $55,000 after purchasing an additional 30 shares during the period. Finally, Eqis Capital Management Inc. boosted its holdings in Waters by 1.0% in the second quarter. Eqis Capital Management Inc. now owns 3,265 shares of the medical instruments supplier’s stock worth $1,128,000 after purchasing an additional 31 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Shares of WAT traded down $5.82 during mid-day trading on Friday, hitting $332.12. 2,154 shares of the company traded hands, compared to its average volume of 477,572. The business has a 50-day moving average of $348.64 and a 200 day moving average of $368.87. The company has a current ratio of 2.47, a quick ratio of 1.89 and a debt-to-equity ratio of 5.47. The stock has a market capitalization of $20.27 billion, a price-to-earnings ratio of 30.31, a PEG ratio of 2.94 and a beta of 0.86. Waters Co. has a one year low of $258.91 and a one year high of $428.22.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, November 2nd. The medical instruments supplier reported $2.66 EPS for the quarter, beating the consensus estimate of $2.34 by $0.32. Waters had a net margin of 25.40% and a return on equity of 271.71%. The company had revenue of $659.23 million during the quarter, compared to analysts’ expectations of $652.28 million. During the same period in the previous year, the company earned $2.16 EPS. As a group, analysts anticipate that Waters Co. will post 11 earnings per share for the current year.

In related news, Director Edward Conard sold 4,000 shares of Waters stock in a transaction on Thursday, December 2nd. The shares were sold at an average price of $336.01, for a total value of $1,344,040.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.10% of the stock is currently owned by company insiders.

Waters Company Profile

Waters Corp. is a specialty measurement company which engages in analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through the Waters and TA segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and related services.

Further Reading: What is an Initial Public Offering (IPO)?

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.